Company Filing History:
4 out of 1,823 
1 out of 7 
1 out of 165 
Years Active: 2004-2018
Title: Ranelle C Salunga: Innovator in Nucleic Acid Amplification and Gene Expression Profiling
Introduction
Ranelle C Salunga is a prominent inventor based in San Diego, California. He has made significant contributions to the field of molecular biology, particularly in the areas of nucleic acid amplification and gene expression profiling. With a total of eight patents to his name, Salunga's work has advanced the understanding and application of genetic technologies.
Latest Patents
Salunga's latest patents include innovative methods for nucleic acid amplification. This invention provides techniques for amplifying nucleic acid molecules, including mRNA, using oligonucleotides, DNA, and RNA polymerases. Additionally, he has developed compositions and kits that facilitate these methods, as well as applications that utilize the amplification products. Another notable patent focuses on gene expression profiling from formalin-fixed, paraffin-embedded (FFPE) samples. This invention offers methods and compositions for generating and utilizing gene expression data from tissue samples, which can enhance the diagnosis and treatment of various diseases.
Career Highlights
Throughout his career, Ranelle C Salunga has worked with leading companies in the biotechnology sector. He has been associated with Life Technologies Corporation and Arcturus Bioscience, Inc., where he has contributed to groundbreaking research and development efforts. His expertise in molecular biology has positioned him as a key player in the advancement of genetic technologies.
Collaborations
Salunga has collaborated with notable professionals in his field, including Mark G Erlander. These partnerships have fostered innovation and have led to the successful development of various technologies that have impacted the biotechnology landscape.
Conclusion
Ranelle C Salunga's contributions to nucleic acid amplification and gene expression profiling have significantly advanced the field of molecular biology. His innovative patents and collaborations reflect his commitment to enhancing genetic technologies for better diagnostic and therapeutic outcomes.